Effectiveness of VR Rehabilitation for People With Asymmetrical Gait Patterns
Evaluation of the Effectiveness of Rehabilitation in Patients With Gait Pattern Asymmetry Using a Virtual Reality
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
A randomized comparative study will be conducted to evaluate the rehabilitation process using a VR-based application versus conventional therapy in 40 patients (sample size determined using a sample size calculator). After meeting the eligibility criteria, participants will be randomly assigned to two groups: the experimental group (20 patients with gait pattern asymmetry), performing a gait training program using a VR rehabilitation application, and the control group (20 patients with gait pattern asymmetry), performing only a conventional gait training program. Participants in both groups will take part in a 2-week rehabilitation program (Monday to Friday), with daily training sessions lasting up to 2 hours. Patient assessment will be conducted twice: an initial evaluation before the start of the intervention (Assessment I) and a follow-up evaluation after completion of the 2-week program (Assessment II), at the same time of day, under the same conditions, and using the same measurement tools.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2027
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2026
CompletedFirst Posted
Study publicly available on registry
May 6, 2026
CompletedStudy Start
First participant enrolled
March 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
Study Completion
Last participant's last visit for all outcomes
August 1, 2027
May 6, 2026
April 1, 2026
3 months
April 28, 2026
April 28, 2026
Conditions
Outcome Measures
Primary Outcomes (8)
Gait speed - 10-meter walk test
Baseline (Day 1)
Gait speed - 10-meter walk test
Immediately after therapy completion (Day 10)
Walking Endurance - 6-Minute Walk Test
Baseline (Day 1)
Walking Endurance - 6-Minute Walk Test
Immediately after therapy completion (Day 10)
Independent Mobility and Fall Risk - Timed "Get Up & Go" Test
Baseline (Day 1)
Independent Mobility and Fall Risk - Timed "Get Up & Go" Test
Immediately after therapy completion (Day 10)
Lower Limb Loading Symmetry - Two-Scale Test
Baseline (Day 1)
Lower Limb Loading Symmetry - Two-Scale Test
Immediately after therapy completion (Day 10)
Secondary Outcomes (4)
Gait and Balance - Dynamic Gait Index
Baseline (Day 1)
Gait and Balance - Dynamic Gait Index
Immediately after therapy completion (Day 10)
Gait Asymmetry - Wisconsin Gait Scale
Baseline (Day 1)
Gait Asymmetry - Wisconsin Gait Scale
Immediately after therapy completion (Day 10)
Study Arms (2)
VR Therapy and Standard Rehabilitation
EXPERIMENTALControl: Standard Rehabilitation
OTHERInterventions
The control group will participate only in a conventional gait training program. Participants will take part in a 2-week rehabilitation program (Monday to Friday), with daily training sessions lasting up to 2 hours. Training will include balance and coordination exercises, proprioceptive stimulation, and exercises aimed at improving step length symmetry and lower limb loading.
The experimental group will participate in a gait training program using a VR rehabilitation application. Participants will take part in a 2-week rehabilitation program (Monday to Friday), with daily training sessions lasting up to 2 hours. Training will include balance and coordination exercises, proprioceptive stimulation, and exercises aimed at improving step length symmetry and lower limb loading. Additionally, the experimental group will receive 15 to 30 minutes (adjusted to the patient's abilities) of training using a VR application in a virtual environment, providing real-time feedback on body position, step length, and balance.
Eligibility Criteria
You may qualify if:
- Diagnosed and clinically confirmed gait pattern asymmetry in the course of neurological diseases
- Informed consent to participate in the study and willingness to comply with rehabilitation recommendations
You may not qualify if:
- Active rheumatic diseases, cancer, advanced diabetes, cardiovascular diseases, and other conditions that may affect the safety and effectiveness of rehabilitation
- Contraindications to VR therapy (epilepsy, motion sickness, dizziness, nausea)
- Lower limb injuries or surgeries within the last 6 months
- Severe mental disorders preventing understanding of instructions
- Lack of informed consent to participate in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Agnieszka Guzik
Rzeszów, Al. Rejtana 16C, Poland 35-310
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
April 28, 2026
First Posted
May 6, 2026
Study Start (Estimated)
March 1, 2027
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
August 1, 2027
Last Updated
May 6, 2026
Record last verified: 2026-04